Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Julie K Jang

Phase 1 Dose-Escalation Study With LEC/Chtnt-3 and Toceranib Phosphate (Palladia) in Dogs With Spontaneous Malignancies

Journal of Cancer Science & Therapy

English

Related publications

A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies

Cancer Research

English

Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination With Bevacizumab in Patients With Advanced Solid Malignancies

Clinical Cancer Research

Cancer Research

English

Ono-4059 (Gs-4059), a Next Generation BTK Inhibitor, Monotherapy in Patients With B-Cell Malignancies in the Japanese Phase 1, Dose-Escalation Study

Hematological Oncology

Cancer Research

English

Phase 1 Dose-Escalation Study of Single-Agent Veliparib in Japanese Patients With Advanced Solid Tumors

Cancer Research

English

A First-In-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients With Advanced Solid Malignancies

Clinical Cancer Research

Cancer Research

English

Assessment of Postoperative Adjuvant Treatment Using Toceranib Phosphate Against Adenocarcinoma in Dogs

Journal of Veterinary Internal Medicine

English

A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine

British Journal of Cancer

Cancer Research

English

Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

British Journal of Haematology

English

Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients With Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

English